Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
294 - Hello, I have a piece that is being reviewed and will likely be available before my required date of 1st use. Is it possible to align the PAAB expiry with the timing of use of my piece.
-
Yes, if your piece is approved prior to your 'intended date of use', we can forward the start date of the acceptance period by a maximum of 3 months from the date of approval. Please advise PAAB of your intended date of use as part of your eFile submission or notify us during the active review process that this date has changed. Please find the link to our Submissions Guidance document and refer to the bottom of page 1 for additional information. http://www.paab.ca/resources/pdfs/code-revision/Guidance_on_Submission_Process.pdf
